Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

SoFi Stock Could Bounce Back, But It’s Not Worth the Risk

By Thomas Niel, InvestorPlace Contributor

Putting it simply, going long SOFI stock in the hopes it bounces back to $17 per share, may not be worth it, if there's a decent risk of market volatility sending it below $10 per share. Wait for uncertainty before buying.

Even After Its Revenue Beat, Stay Away From Clover Stock

By Thomas Niel, InvestorPlace Contributor

While it beat revenue estimates last quarter, there's still plenty that could keep CLOV stock stuck at single-digit prices.

Ocugen Stock Will Suffer Its Inevitable Demise Sooner Rather Than Later

By Thomas Niel, InvestorPlace Contributor

It may take time for it to experience its ultimate collapse. But as its still a matter of if rather than when? Avoid the risk of seeing a double-digit percentage decline. Stay away from OCGN stock.

10 Sports Betting Stocks to Buy Just in Time for Football Season

By Thomas Niel, InvestorPlace Contributor

So, as its prime time once again for sportsbooks, and as the overall igaming trend continues, which sports betting stocks may be of interest? These 10 appear to be top ones to buy.

Consider Quantumscape Stock A Buy Once There’s A Correction

By Thomas Niel, InvestorPlace Contributor

With its high chances of it making a big move lower before it bounces back, why buy QS stock now? Even if bullish on its SSB technology, your best move may be to wait for lower prices.

Only Buy Skillz Stock If You Have a Strong Stomach

By Thomas Niel, InvestorPlace Contributor

If market conditions become more unfavorable for SKLZ stock, further declines may be in store before it starts to take off again.

As its Meme Status Has Come and Gone, Skip Out on Atossa Therapeutics Stock

By Thomas Niel, InvestorPlace Contributor

So, overvalued, with low squeeze odds, what's the best move with ATOS stock? Sell or avoid, before dilution and other factors push it back down to its pre-hype price levels of around $1 per share.

As Long As Legalization Is Possible, Buy Sundial on Any Pullback

By Thomas Niel, InvestorPlace Contributor

If SNDL stock tumbles before it's clear whether U.S. legalization will happen or not, consider this high-risk play a wager worth making.

Wait for a Dip Before Buying Stagnant General Electric Shares

By Thomas Niel, InvestorPlace Contributor

Still somewhat "priced for perfection," investors should wait until more uncertainty is factored into the valuation of GE stock.

The Time to Buy Zomedica Stock May Be Near

By Thomas Niel, InvestorPlace Contributor

After its post-meme collapse, pet healthcare play ZOM stock is still pricey. Wait for it to inch closer to a more optimal entry point.

Load More